GENF.UK GENFLOW BIOSCIENCES PLC
Closed New Year's Day 12-31 12:30:00 GMT Delay
1.80
+0.00
0.00%
High1.80Low1.80Vol0.00
Open1.80D1 Closing1.80Amplitude0.00%
Mkt Cap888.39MTradable Cap377.72MTotal Shares493.55M
T/O0.00T/O Rate0.00%Tradable Shares209.84M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Genflow Biosciences Completes Dosing in Canine Gene Therapy Trial with No Adverse Events
Reuters  ·  2025-12-16
Genflow Biosciences Completes Dosing in Canine Gene Therapy Trial with No Adverse Events
Genflow Biosciences to Attend J.P. Morgan Healthcare Conference
Reuters  ·  2025-12-11
Genflow Biosciences to Attend J.P. Morgan Healthcare Conference
Genflow Biosciences Announces Updated Total Issued Shares and Voting Rights
Reuters  ·  2025-10-31
Genflow Biosciences Announces Updated Total Issued Shares and Voting Rights
BRIEF-Genflow Biosciences PLC - Announces Second European Patent Application Published
Reuters  ·  2025-10-22
BRIEF-Genflow Biosciences PLC - Announces Second European Patent Application Published
Genflow Biosciences Plc - Publication Enables Genflow to Claim Retroactive Damages Under Epc
THOMSON REUTERS  ·  2025-10-22
Genflow Biosciences Plc - Publication Enables Genflow to Claim Retroactive Damages Under Epc
Genflow Biosciences Publishes European Patent Application for SIRT6 Variant Targeting NASH
Reuters  ·  2025-10-22
Genflow Biosciences Publishes European Patent Application for SIRT6 Variant Targeting NASH
Genflow Biosciences’ SIRT6 Variant Patent Claims Recognized as Patentable by European Patent Office
Reuters  ·  2025-10-20
Genflow Biosciences’ SIRT6 Variant Patent Claims Recognized as Patentable by European Patent Office
BRIEF-Genflow Biosciences Says Repeat Administration Of SIRT6 Shows Excellent Safety & Tolerability Profile
Reuters  ·  2025-10-10
BRIEF-Genflow Biosciences Says Repeat Administration Of SIRT6 Shows Excellent Safety & Tolerability Profile
Genflow Biosciences Plc - Repeat Administration of Sirt6 Shows Excellent Safety and Tolerability Profile
THOMSON REUTERS  ·  2025-10-10
Genflow Biosciences Plc - Repeat Administration of Sirt6 Shows Excellent Safety and Tolerability Profile
Genflow Biosciences announces clinical trial update for SIRT6 gene therapy in aging dogs
Reuters  ·  2025-10-10
Genflow Biosciences announces clinical trial update for SIRT6 gene therapy in aging dogs
Genflow Biosciences plc CEO Eric Leire Subscribes for 40 Million New Ordinary Shares in Latest Commercial Paper Deal
Reuters  ·  2025-10-09
Genflow Biosciences plc CEO Eric Leire Subscribes for 40 Million New Ordinary Shares in Latest Commercial Paper Deal
Genflow Biosciences Secures Wallonia Region Grant to Advance SIRT6 Gene Therapy Program GF-1002 Toward Clinical Development
Reuters  ·  2025-09-30
Genflow Biosciences Secures Wallonia Region Grant to Advance SIRT6 Gene Therapy Program GF-1002 Toward Clinical Development
Genflow Biosciences Plc Enters Strategic CDAs with Leading Animal Health Companies to Propel Longevity Gene Therapy Platform
Reuters  ·  2025-09-15
Genflow Biosciences Plc Enters Strategic CDAs with Leading Animal Health Companies to Propel Longevity Gene Therapy Platform

Introduction

Company Name.
GENFLOW BIOSCIENCES PLC
Affiliated Markets:
LSE
Listing Date:
--
Main Business:
Issue price:
--